Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Annals of the Rheumatic Diseases
|
November 18, 2010
Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics Register
M Neovius, Jf Simard, A Sundström, et al.
Plastic and Reconstructive Surgery
|
February 15, 2001
Self-reported symptoms among women after cosmetic breast implant and breast reduction surgery
J P Fryzek, L B Signorello, L Hakelius, et al.
Annals of the Rheumatic Diseases
|
January 18, 2006
Swedish registers to examine drug safety and clinical issues in RA
J Askling, C M Fored, P Geborek, et al.
Annals of the Rheumatic Diseases
|
June 23, 2004
Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept
N Feltelius, C M Fored, P Blomqvist, et al.
Genes and Immunity
|
March 24, 2017
The immunogenetics of narcolepsy associated with A(H1N1)pdm09 vaccination (Pandemrix) supports a potent gene-environment interaction
I L Bomfim, F Lamb, K Fink, et al.
Annals of the Rheumatic Diseases
|
April 15, 2005
Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists
J Askling, C M Fored, L Brandt, et al.
Annals of the Rheumatic Diseases
|
May 10, 2008
Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register
J Askling, E Baecklund, F Granath, et al.
Journal of Internal Medicine
|
July 1, 2015
A coordinated cross-disciplinary research initiative to address an increased incidence of narcolepsy following the 2009-2010 Pandemrix vaccination programme in Sweden
N Feltelius, I Persson, J Ahlqvist-Rastad, et al.
Annals of the Rheumatic Diseases
|
April 22, 2005
Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists
J Askling, C M Fored, E Baecklund, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Annals of the Rheumatic Diseases
|
November 18, 2010
Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics Register
M Neovius, Jf Simard, A Sundström, et al.
Plastic and Reconstructive Surgery
|
February 15, 2001
Self-reported symptoms among women after cosmetic breast implant and breast reduction surgery
J P Fryzek, L B Signorello, L Hakelius, et al.
Annals of the Rheumatic Diseases
|
January 18, 2006
Swedish registers to examine drug safety and clinical issues in RA
J Askling, C M Fored, P Geborek, et al.
Annals of the Rheumatic Diseases
|
June 23, 2004
Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept
N Feltelius, C M Fored, P Blomqvist, et al.
Genes and Immunity
|
March 24, 2017
The immunogenetics of narcolepsy associated with A(H1N1)pdm09 vaccination (Pandemrix) supports a potent gene-environment interaction
I L Bomfim, F Lamb, K Fink, et al.
Annals of the Rheumatic Diseases
|
April 15, 2005
Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists
J Askling, C M Fored, L Brandt, et al.
Annals of the Rheumatic Diseases
|
May 10, 2008
Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register
J Askling, E Baecklund, F Granath, et al.
Journal of Internal Medicine
|
July 1, 2015
A coordinated cross-disciplinary research initiative to address an increased incidence of narcolepsy following the 2009-2010 Pandemrix vaccination programme in Sweden
N Feltelius, I Persson, J Ahlqvist-Rastad, et al.
Annals of the Rheumatic Diseases
|
April 22, 2005
Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists
J Askling, C M Fored, E Baecklund, et al.
Page
of 4